SPG11 antibody (AA 2019-2318)
Quick Overview for SPG11 antibody (AA 2019-2318) (ABIN7170424)
Target
See all SPG11 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 2019-2318
-
Cross-Reactivity
- Human
-
Purification
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Spatacsin protein (2019-2318AA)
-
Isotype
- IgG
-
-
-
-
Application Notes
- Recommended dilution: IF:1:50-1:200,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- SPG11 (Spastic Paraplegia 11 (Autosomal Recessive) (SPG11))
-
Alternative Name
- SPG11
-
Background
-
Background: cytoplasm, cytoplasmic vesicle, extracellular exosome, lysosomal membrane, nucleolus, plasma membrane
Aliases: Colorectal carcinoma associated protein antibody, Colorectal carcinoma-associated protein antibody, DKFZp762B1512 antibody, FLJ21439 antibody, KIAA1840 antibody, Spastic paraplegia 11 (autosomal recessive) antibody, Spastic paraplegia 11 antibody, Spastic paraplegia 11 protein antibody, Spatacsin antibody, SPG 11 antibody, Spg11 antibody, SPTCS_HUMAN antibody
-
UniProt
- Q96JI7
Target
-